Concepedia

Publication | Open Access

ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models

DOIFull Paper Access

40

Citations

31

References

2016

Year

Jadith Ziegler, Richard Pody, Patrícia Coutinho de Souza, Blake Evans, Debra Saunders, Nataliya Smith, Samantha Mallory, Charity Njoku, Yunzhou Dong, Hong Chen,
Neuro-Oncology

Abstract

Either as a single therapy or in conjunction with other therapeutic approaches, anti-ELTD1 antibodies could be a valuable new clinical anti-angiogenic therapeutic for high-grade gliomas.

References

YearCitations

Page 1